|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
|
|---|---|---|---|
| ASSETS | |||
| Current assets | |||
| Cash | |||
| Prepaid expense | |||
| Deferred offering cost | |||
| Total current assets | |||
| Cash held in Trust Account | |||
| TOTAL ASSETS | |||
| LIABILITIES AND STOCKHOLDERS' EQUITY | |||
| Current liabilities | |||
| Accounts payable | |||
| Accrued offering cost | |||
| Promissory note | |||
| Total current liabilities | |||
| TOTAL LIABILITIES | |||
| Class A ordinary shares; $0.0001 par value, subject to possible redemption, 22,750,000 shares at redemption value | |||
| STOCKHOLDERS' EQUITY | |||
| Common stock | |||
| Class A ordinary share | |||
| Class B ordinary share | |||
| Additional paid in capital | |||
| Accumulated deficit | |||
| Total Stockholders' Equity | |||
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY |
Loading...
